Kozuka Yuji, Imai Hiroshi, Yamanaka Mikio, Kozuka Masaki, Uchida Katsunori, Shiraishi Taizo
Department of Pathology, Mie University Hospital.
Nihon Rinsho. 2005 Feb;63(2):231-6.
The diagnosis of prostatic cancer present in a limited amount within needle biopsy tissue, is often challenging. The most common mimickers giving rise to false-positive cancer diagnosis are atypical adenomatous hyperplasia, prostatic intraepithelial neoplasia, atrophy and post-atrophic hyperplasia. Various diagnostic criteria including assessment of basal cells should be used for diagnosis of limited carcinoma. Immunohistochemical staining for both basal cells, such as 34betaE12 and p63, and AMACR, which label the cytoplasm of approximately 80% of prostatic adenocarcinoma, may be a useful adjunct in the diagnosis of limited prostatic cancer. However there are problems with both sensitivity and specificity. When the glands lacking sufficient criteria to establish a definitive carcinoma is present, we use the term 'atypical small acinar proliferation'.
在针吸活检组织中存在少量前列腺癌时,其诊断往往具有挑战性。导致假阳性癌症诊断的最常见模仿者是非典型腺瘤样增生、前列腺上皮内瘤变、萎缩和萎缩后增生。诊断局限性癌应使用包括评估基底细胞在内的各种诊断标准。对基底细胞(如34βE12和p63)以及AMACR进行免疫组化染色,AMACR可标记约80%前列腺腺癌的细胞质,这可能有助于诊断局限性前列腺癌。然而,敏感性和特异性都存在问题。当存在缺乏足够标准来确诊癌的腺体时,我们使用“非典型小腺泡增生”这一术语。